ArticleScientific reports2024

A real-world analysis of FDA Adverse Event Reporting System (FAERS) events for liposomal and conventional doxorubicins.

Huiling Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.